Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization

Topol, 1993, Analysis of coronary angioplasty practice in the United States with insurance-claims data base, Circulation, 87, 1489, 10.1161/01.CIR.87.5.1489 Kern, 1995, Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements, J Am Coll Cardiol, 25, 178, 10.1016/0735-1097(94)00328-N Pijls, 1996, Measurement of fractional flow reserve to asses the functional severity of coronary-artery stenoses, NEJM, 334, 1703, 10.1056/NEJM199606273342604 Kirkeeide, 1986, Assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation: VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions, J Am Coll Cardiol, 87, 1354 Gould, 1990, Coronary flow reserve as a physiologic measure of stenosis severity, J Am Coll Cardiol, 15, 459, 10.1016/S0735-1097(10)80078-6 Pijls, 1993, Experimental basis of determining maximum coronary, myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty, Circulation, 87, 1354, 10.1161/01.CIR.87.4.1354 De Bruyne, 1994, Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography, Circulation, 89, 1013, 10.1161/01.CIR.89.3.1013 De Bruyne, 1994, Rationale and application of coronary transstenotic pressure gradient measurements, Cathet Cardiovasc Diagn, 33, 250, 10.1002/ccd.1810330312 Pijls, 1995, Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events, J Am Coll Cardiol, 25, 1522, 10.1016/0735-1097(95)00111-G Pijls, 1995, Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow, Circulation, 92, 3183, 10.1161/01.CIR.92.11.3183 Scanlon, 1999, ACC AHA guidelines for coronary angiography—a report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography), J Am Coll Cardiol, 33, 1756, 10.1016/S0735-1097(99)00126-6 Berman, 1999, The role of nuclear cardiology in clinical decision making, Semin Nucl Med, 29, 280, 10.1016/S0001-2998(99)80017-8 Fleischmann, 1998, Exercise echocardiography or exercise SPECT imaging? A meta analysis of diagnostic test performances, JAMA, 280, 913, 10.1001/jama.280.10.913 Uren, 1994, Relation between myocardial blood flow and the severity of coronary artery stenosis, N Eng J Med, 330, 1782, 10.1056/NEJM199406233302503 Zaret, 1993, Nuclear cardiology, N Eng J Med, 329, 775, 10.1056/NEJM199309093291107 Henzlova, 2006, Stress protocols and tracers, J Nucl Cardiol, 13, 80, 10.1016/j.nuclcard.2006.08.011 Chuah, 1998, Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease, Circulation, 97, 1474, 10.1161/01.CIR.97.15.1474 Quinones, 1981, A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography, Circulation, 61, 744, 10.1161/01.CIR.64.4.744 Schiller, 1989, Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Pijls, 1995, Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow, Circulation, 92, 3183, 10.1161/01.CIR.92.11.3183 Potvin, 2006, Deferral of revascularization based on fractional flow reserve measurement in patients with acute coronary syndrome and/or non-invasive evidence of myocardial ischemia, Am J Cardiol, 98, 289, 10.1016/j.amjcard.2006.02.032 Giesler, 2002, Long term follow up after deferral of revascularisation in patients with intermediate coronary stenoses and negative dobutamine stress echocardiography, Heart, 88, 645, 10.1136/heart.88.6.645 Davilla-Roman, 1995, Usefulness of dobutamine stress echocardiography for the prospective identification of the physiologic significance of coronary narrowings of moderate severity in patients undergoing evaluation for percutaneous transluminal coronary angioplasty, Am J Cardiol, 76, 245, 10.1016/S0002-9149(99)80074-5 Leesar, 2003, Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcomes, J Am Coll Cardiol, 41, 1115, 10.1016/S0735-1097(03)00057-3 Bech, 1998, Long term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement, J Am Coll Cardiol, 31, 841, 10.1016/S0735-1097(98)00050-3 Ozdemir, 2002, Medium-term follow-up of intermediate coronary stenoses left unrevascularized based on myocardial fractional flow reserve findings, Acta Cardiol, 57, 335, 10.2143/AC.57.5.2005449 Hernandez Garcia, 2001, Clinical management of patients with coronary syndromes and negative fractional flow reserve findings, J Interv Cardiol, 14, 505, 10.1111/j.1540-8183.2001.tb00366.x Lopez-Palop, 2004, Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis, Eur Heart J, 25, 2040, 10.1016/j.ehj.2004.07.016 Chamuleau, 2000, Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis, Am J Cardiol, 89, 377, 10.1016/S0002-9149(01)02255-X Rieber, 2002, Safety of FFR-based treatment strategies: the Munich experience, Z Kardiol, 91, 115, 10.1007/s00392-002-1321-1 Lampe, 2000, The natural history of prevalent ischemic heart disease in middle-aged men, Eur Heart J, 21, 1052, 10.1053/euhj.1999.1866 The EPISTENT Investigators, 1998, Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade, Lancet, 352, 87, 10.1016/S0140-6736(98)06113-3 De Bruyne, 2001, Abnormal epicardial resistance in patients with diffuse atherosclerosis but “normal” coronary angiography, Circulation, 104, 2401, 10.1161/hc4501.099316 Mintz, 1995, Atherosclerosis in angiographically “normal” coronary artery reference: an intravascular ultrasound study with clinical correlations, J Am Coll Cardiol, 25, 1479, 10.1016/0735-1097(95)00088-L Fleischmann, 1998, Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic tests performance, JAMA, 280, 913, 10.1001/jama.280.10.913 Lopez-Palop, 2004, Adequate intracoronary doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional flow reserve: a dose response study, Heart, 90, 95, 10.1136/heart.90.1.95 Murtagh, 2003, Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment, Am Heart J, 146, 99, 10.1016/S0002-8703(03)00120-0 Parham, 2004, Coronary hyperaemic dose responses of intracoronary sodium nitroprusside, Circulation, 109, 1236, 10.1161/01.CIR.0000118470.52908.D9